REGENERON PHARMACEUTICALS's ticker is and the CUSIP is 75886FAD9. A total of 7 filers reported holding REGENERON PHARMACEUTICALS in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LORD, ABBETT & CO. LLC | 2,525,000 | $16,316,000 | 0.05% |
| Vantage Investment Advisors, LLC | 167 | $91,000 | 0.05% |
| Allianz Asset Management GmbH | 4,835,000 | $31,564,000 | 0.04% |
| GABELLI FUNDS LLC | 500,000 | $3,228,000 | 0.02% |
| SSI INVESTMENT MANAGEMENT LLC | 17,000 | $108,000 | 0.01% |
| WELLS FARGO & COMPANY/MN | 3,143,000 | $20,213,000 | 0.01% |
| BANK OF AMERICA CORP /DE/ | 2,000 | $13,000 | 0.00% |